| 6GL9: reference: Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4- d]pyrrolo[2,3- b]pyridine Scaffold., Forster M, Chaikuad A, Dimitrov T, Doring E, Holstein J, Berger BT, Gehringer M, Ghoreschi K, Muller S, Knapp S, Laufer SA, J Med Chem. 2018 Jun 13. doi: 10.1021/acs.jmedchem.8b00571. PMID: 29852068 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).